More cancer survivors prescribed 5 or more unique medications, including medications with abuse potential.
Researchers developed an algorithmic approach to diagnosing lung cavitary diseases.
Nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden.
Majority of patients say they want to know about even minor consequences of cancer drug substitutions.
Dacomitinib is a pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
Findings based on rates in women vs steady decline seen nationally.
An integrated proteomic classifier accurately identified benign lung nodules when used in patients with a pretest probability of malignancy ≤50%.
Independent predictive factors of lung cancer in chronic obstructive pulmonary disease may include frequency of exacerbations, in addition to airflow obstruction and visual emphysema.
Researchers used data from the Atherosclerosis Risk in Communities Study to assess associations between dietary pattern and pulmonary assessments.
During a 10-year period, there was an increase in the rate of commercially insured patients receiving infused chemotherapy in hospital outpatient departments.
Study examines increased physical activity may lower the risk for several cancers and may be beneficial for improving quality of life.
A CHEST expert panel has released updated guidelines for lung cancer screening.
Patients who underwent lung resections had reduced postoperative complication rates when they participated in preoperative exercise.
Mortality rates are higher after surgery vs stereotactic body radiotherapy for patients with early non-small-cell lung cancer.
Lung cancer screening is more effective and efficient for high-risk individuals.
Younger age and higher body mass index may be positive predictors of progression-free survival in patients with squamous cell carcinoma of the lung.
Lack of insurance correlated with a reduced likelihood of chemotherapy and radiation therapy for small cell lung cancer.
Qualitative risk statements of malignancy for indeterminate pulmonary nodules are imprecise, highly variable, and should be replaced by a standard scale.
The cancer death rate declined by 1.5% annually from 2006 to 2015 in the United States.